BOSTON--(BUSINESS WIRE)--par8o, Healthcare’s Operating System, today announced the addition of Jonathan “Jack” Lord, M.D. to its Board of Directors. A nationally recognized leader in innovation in healthcare, Dr. Lord is known for driving change through new technologies and therapies.
“As a physician, entrepreneur and innovator, Dr. Lord brings a unique insight into healthcare trends and how to build and scale a technology company, so we are thrilled to have him join our Board,” said Daniel Palestrant, MD, co-founder and CEO at par8o. “At par8o, we are transforming the relationships between patients, providers and payers, and given Dr. Lord’s breadth of experience, he will provide valuable insight into these market segments that will help to accelerate par8o’s growth.”
Dr. Lord is a board-certified forensic pathologist and fellow of the College of American Pathologists. He began his medical career in the U.S. Navy, serving for 11 years in a number of leadership roles in the Navy medical department. He later served as a senior executive in a variety of healthcare organizations – the Anne Arundel Medical Center, SunHealth, and as the chief operating officer of the American Hospital Association. As the former chief innovation officer and senior vice president of Humana, Dr. Lord created Humana’s Innovation Center, which combined research, technology and consumer experience to promote health and well-being. He also contributed to the field of predictive sciences by using advanced analytics to predict future illness and prevent disease. Recently, he served as the chief innovation officer and chief operating officer of the Miller School of Medicine at the University of Miami. He is a double alumnus of the University of Miami and has earned certificates in governance and audit from the Harvard Business School.
“With the advent of the ACA and accountable care, the goals of patients, providers and payers have become much more aligned. The vision that par8o has for the healthcare industry, along with the technologies it provides, will truly transform how these groups work together and how care is delivered in this country,” said Dr. Lord. “The healthcare industry has reached a tipping point and par8o is leading the charge, and I’m excited to be a part of it.”
Dr. Lord has served as a member of a number of prestigious boards and organizations, including the Centers for Disease Control and Prevention’s Advisory Committee to the director; the National Advisory Council for Healthcare Research and Quality, which advises the U.S. Secretary of Health and Human Services; and the editorial board for the International Journal of Healthcare Management. Today he also serves as the chair of the Board of Directors of Dexcom (DXCM), is a director for Biolase (BIOL), Digital Reasoning, and Velano Vascular. He also serves on advisory board roles for Third Rock Ventures and ViaGenetics. His previous academic appointments include Dartmouth Medical School, George Washington University and the Eastern Virginia School of Medicine.
About par8o
par8o is a venture-backed, EMR-agnostic platform
that creates a common point for coordinating care delivery and plan
design, a technology that connects providers, payers, and patients. The
par8o platform acts as a cloud-based healthcare operating system
enabling all parties to improve care and optimize towards several
clinical and business goals in parallel rather than to the detriment of
one another. par8o helps clients succeed by applying Pareto
Optimization, a powerful economic principle that succeeds because it is
well suited to the complex, multi-constituency nature of healthcare.
Simply put, par8o helps organizations match the right patient to the
right resource at the right time. To learn more about par8o, please
visit www.par8o.com.